Can Mitochondrial Pathway Inhibition Be Therapeutic?
Yes, targeting the mitochondrial pathway can have therapeutic potential. Inhibitors of the mitochondrial pathway, such as Bcl-2 family proteins, can promote cell survival by preventing apoptosis. This approach can be beneficial in conditions where excessive apoptosis contributes to disease pathogenesis, such as in neurodegenerative diseases.
